Pepticinnamins N, O and P, cytotoxic non-ribosomal peptides from a Soil-Derived Streptomyces mirabilis P8-A2

Ling Ding,Manar Mahmoud,Maria Mahmoud Abboud,Matiss Maleckis,Luciano D. O. Souza,José M. A. Moreira,Charlotte H. Gotfredsen,Tilmann Weber
DOI: https://doi.org/10.26434/chemrxiv-2024-4gjgb
2024-02-23
Abstract:Cinnamoyl moiety containing non-ribosomal peptides represented by pepticinnamin E, are a growing family of natural products isolated from different Streptomyces and possess diverse bioactivities. A soil bacterium Streptomyces mirabilis P8-A2 harbors a cryptic pepticinnamin biosynthetic gene cluster, producing azodyrecins as major products. Inactivation of the azodyrecin biosynthetic gene cluster by CRISPR-BEST base editing led to the activation and production of pepticinnamin E (1) and its analogues, pepticinnamins N, O and P (2-4), the structures of which were determined by detailed NMR spectroscopy, HRMS data, and Marfey´s reactions. These new compounds exerted modest growth inhibitory effect against the LNCaP and C4-2B prostate cancer lines, respectively, with pepticinnamin O being the most active.
Chemistry
What problem does this paper attempt to address?
### Problems Addressed by the Paper The paper primarily explores new non-ribosomal peptides—iPepticinnamins N, O, and P—isolated from soil-derived *Streptomyces mirabilis* P8-A2, and investigates their structural characteristics and biological activities. #### Main Research Content: 1. **Gene Cluster Activation**: The gene cluster responsible for producing azodyrecins was inactivated using CRISPR-BEST base editing technology, thereby activating and producing pepticinnamin E and its analogs pepticinnamins N, O, and P. 2. **Structural Identification**: The structures of these new compounds were determined using detailed nuclear magnetic resonance (NMR) spectroscopy, high-resolution mass spectrometry (HRMS) data, and Marfey's reaction. 3. **Biological Activity Testing**: These new compounds exhibited certain growth inhibitory effects on prostate cancer cell lines (LNCaP and C4-2B), with pepticinnamin O showing the most significant inhibitory effect. #### Background and Methods: - **Background**: Although the genome diversity of *Streptomyces* is vast, most secondary metabolites remain unknown under standard laboratory culture conditions. Various methods, including genetic manipulation, heterologous expression, and co-cultivation, can be used to activate the production of these compounds. - **Methods**: The core gene azdB in the azodyrecin biosynthetic gene cluster was inactivated using gene editing technology, leading to the substantial production of pepticinnamins. Multiple analytical techniques (such as LC-MS, NMR, etc.) were used to identify the structures of the new compounds, and biological activity tests were conducted. #### Conclusion: - The biosynthetic gene cluster of pepticinnamins was successfully activated through gene editing technology, and three new pepticinnamin analogs (N, O, and P) were identified for the first time. - These new compounds exhibited certain inhibitory effects on prostate cancer cell lines, with pepticinnamin O showing better activity. In summary, the paper successfully identified new non-ribosomal peptide compounds through gene editing technology and multiple analytical methods, and conducted preliminary evaluations of their biological activities.